Lapatinib Ditosylate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Lapatinib Ditosylate
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Lapatinib Ditosylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 10 USDMF, 1 JDMF, 5 EU WC, 1 KDMF, 11 NDC API, 23 Listed Suppliers, $ API Reference Price

30 API Suppliers
10 USDMF
1 JDMF
5 EU WC
1 KDMF
11 NDC API
23 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

22 Intermediate Suppliers

22 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

16 FDF Dossiers, 3 FDA Orange Book, 6 Europe, 2 Australia, 1 South Africa, 4 Listed Dossiers

16 FDF Dossiers
3 FDA Orange Book
6 Europe
2 Australia
1 South Africa
4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Seqens, 2 DKSH, 2 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 27 Fillers, Diluents & Binders, 26 Controlled & Modified Release, 21 Solubilizers, 18 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 14 Granulation, 13 Direct Compression, 10 Topical, 10 Lubricants & Glidants, 10 Film Formers & Plasticizers, 9 Parenteral, 6 Co-Processed Excipients, 5 Emulsifying Agents, 5 Empty Capsules, 4 Taste Masking, 4 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents

44 Coating Systems & Additives
27 Fillers, Diluents & Binders
26 Controlled & Modified Release
21 Solubilizers
18 Thickeners and Stabilizers
15 Disintegrants & Superdisintegrants
14 Granulation
13 Direct Compression
10 Topical
10 Lubricants & Glidants
10 Film Formers & Plasticizers
9 Parenteral
6 Co-Processed Excipients
5 Emulsifying Agents
5 Empty Capsules
4 Taste Masking
4 Coloring Agents
4 Vegetarian Capsules
4 API Stability Enhancers
3 Rheology Modifiers
3 Chewable & Orodispersible Aids
2 Surfactant & Foaming Agents

DIGITAL CONTENT

14 NEWS #PharmaBuzz

14 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 6 Finished Drug Prices

2 US Medicaid Prescriptions
6 Finished Drug Prices

MARKET PLACE

1 APIs, 9 FDF Dossiers

1 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 3 Health Canada Patents

1 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 Others

8 Others

$ API Ref.Price (USD/KG) : 2,921 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 2Gowling WLG (Canada) LLP

02 1Gowlings

filter Patent Reset all filters

3 All

01 12317589

02 12413134

03 12606207

filter Product Reset all filters

3 All

01 3Lapatinib Ditosylate Monohydrate

filter Dosage Reset all filters

3 All

01 3Tablet

filter Exp Date Reset all filters

3 All

01 12019-01-08

02 12021-06-28

03 12026-04-18

Product Main Page

01

Gowlings

Lapatinib Ditosylate

BioAsia

Not Confirmed

Gowlings

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-01-08

Date Granted : 2007-08-07

Lapatinib Ditosylate

Brand Name : TYKERB

Patent Number : 2317589

Filing Date : 1999-01-08

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-01-08

Date Granted : 2007-08-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Lapatinib Ditosylate

BioAsia

Not Confirmed

Gowling WLG (Canada) LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-06-28

Date Granted : 2010-05-11

Lapatinib Ditosylate

Brand Name : TYKERB

Patent Number : 2413134

Filing Date : 2001-06-28

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-06-28

Date Granted : 2010-05-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Lapatinib Ditosylate

BioAsia

Not Confirmed

Gowling WLG (Canada) LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-18

Date Granted : 2014-11-18

Lapatinib Ditosylate

Brand Name : TYKERB

Patent Number : 2606207

Filing Date : 2006-04-18

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-04-18

Date Granted : 2014-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!